Before a new medicine can be used in the NHS, it must be licensed and evaluated to ensure that it works and will be cost-effective.

Before a new medicine can be used in the NHS, it must be licensed and evaluated to ensure that it works and will be cost-effective.

Mr Speaker, you are remarkable for sitting here for all this time. I share the admiration for you, if not your football team after Sunday afternoon. Less said about that the better. I cannot even believe I have raised it. I know that you will have been there and will...

Mr Speaker, you are remarkable for sitting here for all this time. I share the admiration for you, if not your football team after Sunday afternoon. Less said about that the better. I cannot even believe I have raised it. I know that you will have been there and will...

Would it be right to say that the consultation assumed there would be a charging mechanism and that it was not about whether but about how?

Would it be right to say that the consultation assumed there would be a charging mechanism and that it was not about whether but about how?

Yes, the consultation was about how, but we are listening very carefully to the “how”.

As my hon. Friend said, Members have expressed concern that the introduction of the charging mechanism will make us a less attractive country in which to invest. We are committed to ensuring that the UK is...

Yes, the consultation was about how, but we are listening very carefully to the “how”.

As my hon. Friend said, Members have expressed concern that the introduction of the charging mechanism will make us a less attractive country in which to invest. We are committed to ensuring that the UK is...

I thank the Minister for answering my last intervention so honestly. Given that the last consultation was not about the “whether” but about the “how”, may I ask if there was ever a consultation on

whether this was the most appropriate way to ensure better value and more money for...

I thank the Minister for answering my last intervention so honestly. Given that the last consultation was not about the “whether” but about the “how”, may I ask if there was ever a consultation on

whether this was the most appropriate way to ensure better value and more money for...

Not to the best of my knowledge, but this will of course continue through the NICE review process next year, and I have no doubt that my hon. Friend will be able to discuss this at great length with Lord O’Shaughnessy on Thursday.

I stress that the Government share the views...

Not to the best of my knowledge, but this will of course continue through the NICE review process next year, and I have no doubt that my hon. Friend will be able to discuss this at great length with Lord O’Shaughnessy on Thursday.

I stress that the Government share the views...

Agreed to on question.

Agreed to on question.

I rise to speak about health technology assessment charges in England. I am sad to see that there is not more interest in this debate, even at this very interesting early hour of the morning.

The Government are proposing to charge for technology appraisals undertaken by the National Institute for Health...

I rise to speak about health technology assessment charges in England. I am sad to see that there is not more interest in this debate, even at this very interesting early hour of the morning.

The Government are proposing to charge for technology appraisals undertaken by the National Institute for Health...

To ask the Secretary of State for Health, if he will investigate the potential conflict of interest at the Health Technology Assessment Programme for those people responsible for awarding funding for the CLOTHES clinical trials who were also heading the Nottingham Clinical Trials Unit to which funding was ultimately granted.

To ask the Secretary of State for Health, if he will investigate the potential conflict of interest at the Health Technology Assessment Programme for those people responsible for awarding funding for the CLOTHES clinical trials who were also heading the Nottingham Clinical Trials Unit to which funding was ultimately granted.

To ask the Secretary of State for Health, if he will investigate the potential conflict of interest within the Health Technology Assessment Programme whereby some people responsible for awarding funding for the CLOTHES clinical trials were simultaneously heading the Nottingham Clinical Trials Unit to which such funding was granted.

To ask the Secretary of State for Health, if he will investigate the potential conflict of interest within the Health Technology Assessment Programme whereby some people responsible for awarding funding for the CLOTHES clinical trials were simultaneously heading the Nottingham Clinical Trials Unit to which such funding was granted.

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.[Journal article] By P. Barton et al. Health Technology Assessment 2004;8:(11). 104 p.

The use of modelling to evaluate new drugs for patients with a chronic condition: the case of antibodies against tumour necrosis factor in rheumatoid arthritis.[Journal article] By P. Barton et al. Health Technology Assessment 2004;8:(11). 104 p.

To ask the Secretary of State for Health, what is the (a) membership and (b) remit of the National Co-ordinating Centre for Health Technology Assessment. - Including ref to the NCCHTA website (www.ncchta.org).

To ask the Secretary of State for Health, what is the (a) membership and (b) remit of the National Co-ordinating Centre for Health Technology Assessment. - Including ref to the NCCHTA website (www.ncchta.org).

Letter from Yvette Cooper, MP to Gareth R Thomas, MP, following adjournment debate of 2 Feb 2001, concerning funding provided for a study on the effectiveness of new and old drugs for Parkinsons disease. DH. 2001.

Letter from Yvette Cooper, MP to Gareth R Thomas, MP, following adjournment debate of 2 Feb 2001, concerning funding provided for a study on the effectiveness of new and old drugs for Parkinsons disease. DH. 2001.

Three reports from the National Screening Committee and the Health Technology Programme regarding screening for Cystic Fibrosis and Diabetes. DH. 1999

Three reports from the National Screening Committee and the Health Technology Programme regarding screening for Cystic Fibrosis and Diabetes. DH. 1999

To ask the Secretary of State for Health, What recent discussions he has held with local health authorities regarding the prevention and treatment of prostate cancer in men in their areas; and if he will make a statement. (Failed OPQ). - Includes figures.

To ask the Secretary of State for Health, What recent discussions he has held with local health authorities regarding the prevention and treatment of prostate cancer in men in their areas; and if he will make a statement. (Failed OPQ). - Includes figures.

To ask the Secretary of State for Health, if he will list his Department's expenditure on the health technology assessment for each year from 1992 to 1998. - Inc table and ref to Annual Report of the NHS Health Technology Assessment Programme 1998.

To ask the Secretary of State for Health, if he will list his Department's expenditure on the health technology assessment for each year from 1992 to 1998. - Inc table and ref to Annual Report of the NHS Health Technology Assessment Programme 1998.

To ask the Secretary of State for Northern Ireland, if she will list the research and development by (a) her Department and (b) the NHS, indicating separately that on health technology assessment each year since 1992. - Includes table.

To ask the Secretary of State for Northern Ireland, if she will list the research and development by (a) her Department and (b) the NHS, indicating separately that on health technology assessment each year since 1992. - Includes table.

What are the reasons for the delay in publishing the Health Technology Assessment Project on cost effectiveness of MRI in the DGH; when he plans to publish it. - Will write.

What are the reasons for the delay in publishing the Health Technology Assessment Project on cost effectiveness of MRI in the DGH; when he plans to publish it. - Will write.